| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c8fb7e85a6f61273fe3472d4fc675e5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D475-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate |
2003-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f209378b7218f201f77ba0184709169
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dce09c101535154484e2ddcbe1351b58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18aeef685808f46b56cc7b9ca4be2037
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35872a6ce50dcaf65a56b17c0539a3ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e5d33ce663fece79b4c341fd72182fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c479a999c6d77f6672e9006ad50b212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf006df4dc7dcbee45505844b14207fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65eb3e93210d70aac6073d672ae5b037
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69222e35c9564b5178cee8d70c071051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_282a39a9d0faa219823ccab300c384ed |
| publicationDate |
2006-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006004011-A1 |
| titleOfInvention |
Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| abstract |
This invention relates to a compound of Formula I (I) and its use in treating hyper-proliferative disorders and diseases associated with angiogenesis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008033999-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018030800-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7897762-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009099190-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010069381-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8492378-B2 |
| priorityDate |
2003-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |